[go: up one dir, main page]

EE9700087A - Uued immunomodulatoorse toimega peptiidid - Google Patents

Uued immunomodulatoorse toimega peptiidid

Info

Publication number
EE9700087A
EE9700087A EE9700087A EE9700087A EE9700087A EE 9700087 A EE9700087 A EE 9700087A EE 9700087 A EE9700087 A EE 9700087A EE 9700087 A EE9700087 A EE 9700087A EE 9700087 A EE9700087 A EE 9700087A
Authority
EE
Estonia
Prior art keywords
immunomodulatory activity
novel peptides
peptides
novel
immunomodulatory
Prior art date
Application number
EE9700087A
Other languages
English (en)
Estonian (et)
Inventor
Bergstrand H�kan
Erikson Tomas
Karabelas Kostas
Lindvall Magnus
S�rnstrand Bengt
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9700087A publication Critical patent/EE9700087A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EE9700087A 1994-10-14 1995-10-06 Uued immunomodulatoorse toimega peptiidid EE9700087A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9403526A SE9403526D0 (sv) 1994-10-14 1994-10-14 New Peptides
PCT/SE1995/001151 WO1996011943A1 (en) 1994-10-14 1995-10-06 New peptides with immunomodulatory effects

Publications (1)

Publication Number Publication Date
EE9700087A true EE9700087A (et) 1997-10-15

Family

ID=20395628

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700087A EE9700087A (et) 1994-10-14 1995-10-06 Uued immunomodulatoorse toimega peptiidid

Country Status (20)

Country Link
US (2) US6103697A (is)
EP (1) EP0783519A1 (is)
JP (1) JPH10507448A (is)
AU (1) AU705364B2 (is)
BR (1) BR9509345A (is)
CA (1) CA2201479A1 (is)
CZ (1) CZ111997A3 (is)
EE (1) EE9700087A (is)
FI (1) FI971499L (is)
HU (1) HUT77118A (is)
IL (1) IL115509A0 (is)
IS (1) IS4459A (is)
MX (1) MX9702666A (is)
NO (1) NO971625L (is)
PL (1) PL319631A1 (is)
SE (1) SE9403526D0 (is)
SK (1) SK46797A3 (is)
TR (1) TR199501255A2 (is)
WO (1) WO1996011943A1 (is)
ZA (1) ZA958140B (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
EP0923604A1 (en) * 1996-04-12 1999-06-23 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory effects
EP0914143A1 (en) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
SE9603462D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603467D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603466D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603461D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603465D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
US20010049381A1 (en) 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
WO1999019347A1 (en) * 1997-10-10 1999-04-22 Astrazeneca Ab Synthetic genes with immunomodulatory effects
AU761083B2 (en) * 1998-06-03 2003-05-29 Gpi Nil Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
RU2144374C1 (ru) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
AU2006238906B2 (en) 2005-04-25 2013-04-11 Cadila Pharmaceuticals Ltd. Vaccine adjuvants
KR101363455B1 (ko) * 2011-09-09 2014-02-21 (주)케어젠 매트릭스 메탈로프로테아제 활성 억제 펩타이드 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
EP0300031A4 (en) 1987-01-28 1990-05-14 Ortho Pharma Corp IMMUNODEPRESSANT PEPTIDES AND METHODS OF USE THEREOF.
FR2622700B1 (fr) 1987-10-30 1993-08-13 Aderegem Proteine et ses fragments representant l'expression specifique du gene ps2 des cancers du sein, anticorps obtenus a partir de ladite proteine et/ou de ses fragments, leurs applications a la detection et au diagnostic de cancers du sein
WO1989010935A1 (en) * 1988-05-09 1989-11-16 Abbott Laboratories Atrial peptide derivatives
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
JP2596466B2 (ja) 1990-03-03 1997-04-02 アサヒビール株式会社 ダニの主要アレルゲンの還伝情報を有するｄｎａおよび該アレルゲンの製造方法
JP3592709B2 (ja) 1990-09-11 2004-11-24 インスティテュート・フォー・チャイルド・ヘルス・リサーチ ダーマトファゴイデス（家塵ダニ）のアレルゲンのクローニングおよびシークエンシング
WO1993000108A1 (en) * 1991-06-28 1993-01-07 Corvas International, Inc. Novel inhibitors of platelet aggregation
JP2657861B2 (ja) 1991-09-17 1997-09-30 アサヒビール株式会社 ダニ主要アレルゲンの製造方法
ATE444360T1 (de) 1991-10-16 2009-10-15 Merck Patent Gmbh T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
JP3149033B2 (ja) 1991-10-30 2001-03-26 アサヒビール株式会社 ダニ主要アレルゲンＤｅｒ ｆ ＩＩ中のペプチド
JP3908271B2 (ja) 1993-03-05 2007-04-25 エピミューン，インコーポレイティド Ｈｌａ−ａ２．１結合ペプチドおよびそれらの使用
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
JPH07215996A (ja) 1994-01-31 1995-08-15 Torii Yakuhin Kk ダニアレルゲンのｂ細胞エピトープ
WO1996001318A1 (en) 1994-07-05 1996-01-18 Steeno Research Group A/S Immunomodulators
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides

Also Published As

Publication number Publication date
WO1996011943A1 (en) 1996-04-25
FI971499A7 (fi) 1997-06-10
NO971625D0 (no) 1997-04-09
TR199501255A2 (tr) 1996-06-21
US6228374B1 (en) 2001-05-08
FI971499L (fi) 1997-06-10
HUT77118A (hu) 1998-03-02
PL319631A1 (en) 1997-08-18
SE9403526D0 (sv) 1994-10-14
EP0783519A1 (en) 1997-07-16
SK46797A3 (en) 1997-09-10
AU3713395A (en) 1996-05-06
US6103697A (en) 2000-08-15
NO971625L (no) 1997-05-30
JPH10507448A (ja) 1998-07-21
BR9509345A (pt) 1997-11-25
CA2201479A1 (en) 1996-04-25
FI971499A0 (fi) 1997-04-10
ZA958140B (en) 1997-06-27
MX9702666A (es) 1997-06-28
CZ111997A3 (en) 1997-12-17
AU705364B2 (en) 1999-05-20
IS4459A (is) 1997-04-08
IL115509A0 (en) 1996-05-14

Similar Documents

Publication Publication Date Title
FI961350A7 (fi) Hapteenimerkityt peptidit
FI965225A7 (fi) Uusia peptidejä
EP0671926A4 (en) Immunomodulatory peptides.
DK91192D0 (da) Protein
EE9700087A (et) Uued immunomodulatoorse toimega peptiidid
FI954147L (fi) Polypeptidejä
FI953302A7 (fi) Uudet peptidit
NO976058L (no) Rekombinant mistellectin
DE59502973D1 (de) Verbindungsanordnung
FI940109A7 (fi) Peptidejä
GB9425582D0 (en) Peptides having immunomodulatory activity
FI970168A7 (fi) Peptidejä
EE9600208A (et) Uued immuunomodulatoorse toimega peptiidid
FI964363L (fi) Peptidejä
KR960010685A (ko) 펩티드 및 그 용도
DK0713916T3 (da) Rekombinant beta-amylase
AT397725B (de) Elektrodenanordnung
FI963747A7 (fi) Kytkentäjärjestely
FI943329A7 (fi) Liitosjärjestely
ATA63694A (de) Elektrodenanordnung
DE69434900D1 (de) Menschliche chemokin-polypeptide
DK120792D0 (da) Protein
KR960003039U (ko) 개선된 파마로이
DE69403949D1 (de) Verbindungsarchitekturen
DE69521181D1 (de) Verbindungsanordnung